NYSE:CC - The Chemours Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$51.79 -0.73 (-1.39 %)
(As of 05/23/2018 01:37 AM ET)
Previous Close$51.79
Today's Range$51.69 - $52.86
52-Week Range$34.84 - $58.08
Volume1.13 million shs
Average Volume1.72 million shs
Market Capitalization$9.28 billion
P/E Ratio13.56
Dividend Yield1.30%
Beta2.96

About The Chemours (NYSE:CC)

The Chemours logoThe Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging. The Fluoroproducts segment provides fluoroproducts, including refrigerants, and industrial fluoropolymer resins and derivatives under the Teflon, Viton, Krytox, and Nafion brand names. The Chemical Solutions segment offers industrial and specialty chemicals for gold production, oil and gas, water treatment, electronics, and automotive industries. It also provides sodium cyanide through its mining solutions business; and performance chemicals and intermediates, such as methylamines, glycolic acid, and Vazo free radical initiators. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.

Receive CC News and Ratings via Email

Sign-up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustryN/A
SectorBasic Materials
SymbolNYSE:CC
CUSIPN/A
Phone302-773-1000

Debt

Debt-to-Equity Ratio4.13
Current Ratio2.21
Quick Ratio1.60

Price-To-Earnings

Trailing P/E Ratio13.56
Forward P/E Ratio9.10
P/E Growth0.59

Sales & Book Value

Annual Sales$6.18 billion
Price / Sales1.49
Cash Flow$5.4401 per share
Price / Cash9.52
Book Value$4.67 per share
Price / Book11.09

Profitability

EPS (Most Recent Fiscal Year)$3.82
Net Income$746 million
Net Margins13.79%
Return on Equity107.89%
Return on Assets12.09%

Miscellaneous

Employees7,000
Outstanding Shares177,910,000

The Chemours (NYSE:CC) Frequently Asked Questions

What is The Chemours' stock symbol?

The Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."

How often does The Chemours pay dividends? What is the dividend yield for The Chemours?

The Chemours declared a quarterly dividend on Tuesday, May 1st. Shareholders of record on Thursday, May 17th will be paid a dividend of $0.17 per share on Friday, June 15th. This represents a $0.68 annualized dividend and a yield of 1.31%. The ex-dividend date is Wednesday, May 16th. View The Chemours' Dividend History.

How will The Chemours' stock buyback program work?

The Chemours announced that its Board of Directors has authorized a share repurchase program on Monday, December 4th 2017, which authorizes the company to buyback $500,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to purchase shares of its stock through open market purchases. Shares buyback programs are typically an indication that the company's board of directors believes its shares are undervalued.

How were The Chemours' earnings last quarter?

The Chemours Company (NYSE:CC) released its quarterly earnings results on Thursday, May, 3rd. The specialty chemicals company reported $1.41 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.22 by $0.19. The specialty chemicals company earned $1.73 billion during the quarter, compared to analysts' expectations of $1.65 billion. The Chemours had a net margin of 13.79% and a return on equity of 107.89%. The firm's revenue was up 20.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.75 EPS. View The Chemours' Earnings History.

When is The Chemours' next earnings date?

The Chemours is scheduled to release their next quarterly earnings announcement on Wednesday, August, 1st 2018. View Earnings Estimates for The Chemours.

What price target have analysts set for CC?

10 analysts have issued 12-month price objectives for The Chemours' stock. Their forecasts range from $55.00 to $69.00. On average, they expect The Chemours' share price to reach $60.9444 in the next year. View Analyst Ratings for The Chemours.

Who are some of The Chemours' key competitors?

Who are The Chemours' key executives?

The Chemours' management team includes the folowing people:
  • Mr. Mark P. Vergnano, Pres, CEO & Director (Age 60)
  • Mr. Mark E. Newman, Sr. VP & CFO (Age 55)
  • Mr. David C. Shelton Esq., Sr. VP, Gen. Counsel & Corp. Sec. (Age 54)
  • Mr. E. Bryan Snell, Pres of Titanium Technologies (Age 61)
  • Mr. Paul Kirsch, Pres of Fluoroproducts Bus. (Age 54)

Has The Chemours been receiving favorable news coverage?

News articles about CC stock have been trending somewhat positive on Tuesday, Accern Sentiment Analysis reports. Accern identifies positive and negative media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. The Chemours earned a news impact score of 0.15 on Accern's scale. They also assigned news coverage about the specialty chemicals company an impact score of 46.62 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

Who are The Chemours' major shareholders?

The Chemours' stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (9.88%), Iridian Asset Management LLC CT (2.56%), Prudential Financial Inc. (2.16%), Allianz Asset Management GmbH (1.39%), Northern Trust Corp (0.96%) and Point72 Asset Management L.P. (0.92%). Company insiders that own The Chemours stock include Amy Trojanowski, Christian W Siemer, David C Shelton, E Bryan Snell, Erich Parker, Mark Newman, Mark P Vergnano, Paul Kirsch and Richard H Brown. View Institutional Ownership Trends for The Chemours.

Which major investors are selling The Chemours stock?

CC stock was sold by a variety of institutional investors in the last quarter, including Columbus Circle Investors, Natixis, Hsbc Holdings PLC, JPMorgan Chase & Co., Spark Investment Management LLC, Caisse DE Depot ET Placement DU Quebec, Thrivent Financial for Lutherans and Swiss National Bank. Company insiders that have sold The Chemours company stock in the last year include Amy Trojanowski, Christian W Siemer, David C Shelton, E Bryan Snell, Erich Parker, Mark Newman, Mark P Vergnano and Paul Kirsch. View Insider Buying and Selling for The Chemours.

Which major investors are buying The Chemours stock?

CC stock was bought by a variety of institutional investors in the last quarter, including Iridian Asset Management LLC CT, First Eagle Investment Management LLC, Point72 Asset Management L.P., Millennium Management LLC, Scopus Asset Management L.P., Carillon Tower Advisers Inc., Allianz Asset Management GmbH and LSV Asset Management. View Insider Buying and Selling for The Chemours.

How do I buy shares of The Chemours?

Shares of CC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is The Chemours' stock price today?

One share of CC stock can currently be purchased for approximately $51.79.

How big of a company is The Chemours?

The Chemours has a market capitalization of $9.28 billion and generates $6.18 billion in revenue each year. The specialty chemicals company earns $746 million in net income (profit) each year or $3.82 on an earnings per share basis. The Chemours employs 7,000 workers across the globe.

How can I contact The Chemours?

The Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19899. The specialty chemicals company can be reached via phone at 302-773-1000 or via email at [email protected]


MarketBeat Community Rating for The Chemours (CC)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  194 (Vote Outperform)
Underperform Votes:  235 (Vote Underperform)
Total Votes:  429
MarketBeat's community ratings are surveys of what our community members think about The Chemours and other stocks. Vote "Outperform" if you believe CC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CC will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

The Chemours (NYSE:CC) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
10 Wall Street analysts have issued ratings and price targets for The Chemours in the last 12 months. Their average twelve-month price target is $60.9444, suggesting that the stock has a possible upside of 17.68%. The high price target for CC is $69.00 and the low price target for CC is $55.00. There are currently 3 hold ratings and 7 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.702.702.672.88
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $60.9444$59.65$57.9444$53.50
Price Target Upside: 17.68% upside22.41% upside8.13% upside3.18% upside

The Chemours (NYSE:CC) Consensus Price Target History

Price Target History for The Chemours (NYSE:CC)

The Chemours (NYSE:CC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/21/2018Vertical ResearchInitiated CoverageBuyLowView Rating Details
5/8/2018CitigroupBoost Price TargetBuy ➝ Buy$66.00 ➝ $69.00LowView Rating Details
5/8/2018BarclaysReiterated RatingBuy$64.00LowView Rating Details
3/27/2018BMO Capital MarketsInitiated CoverageOutperform$68.00MediumView Rating Details
1/30/2018Morgan StanleyInitiated CoverageEqual ➝ Equal Weight$57.50MediumView Rating Details
12/6/2017Goldman SachsDowngradeBuy ➝ Neutral$55.00MediumView Rating Details
12/4/2017Jefferies GroupBoost Price TargetBuy$66.00HighView Rating Details
11/3/2017UBSBoost Price TargetNeutral$50.00 ➝ $59.00N/AView Rating Details
8/10/2017ArgusReiterated RatingBuy$50.00 ➝ $55.00HighView Rating Details
8/4/2017JPMorgan ChaseBoost Price TargetOverweight$55.00LowView Rating Details
5/15/2017Susquehanna BancsharesBoost Price TargetPositive$45.00 ➝ $55.00LowView Rating Details
(Data available from 5/23/2016 forward)

Earnings

The Chemours (NYSE:CC) Earnings History and Estimates Chart

Earnings by Quarter for The Chemours (NYSE:CC)

The Chemours (NYSE:CC) Earnings Estimates

2018 EPS Consensus Estimate: $5.51
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$1.26$1.26$1.26
Q2 20181$1.42$1.42$1.42
Q3 20181$1.36$1.36$1.36
Q4 20181$1.47$1.47$1.47

The Chemours (NYSE CC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/31/2018$1.57N/AView Earnings Details
5/3/2018Q1 2018$1.22$1.41$1.6486 billion$1.73 billionViewN/AView Earnings Details
2/14/2018Q4 2017$0.95$1.19$1.5535 billion$1.5750 billionViewListenView Earnings Details
11/2/2017Q3 2017$1.01$1.12$1.5881 billion$1.5840 billionViewN/AView Earnings Details
8/2/2017Q2 2017$0.85$0.87$1.4889 billion$1.5880 billionViewListenView Earnings Details
5/1/2017Q1 2017$0.5010$0.75$1.3238 billion$1.4370 billionViewListenView Earnings Details
2/15/2017Q416$0.29$0.08$1.24 billion$1.30 billionViewN/AView Earnings Details
11/6/2016Q3 2016$0.25$0.61$1.2950 billion$1.3980 billionViewN/AView Earnings Details
8/8/2016Q216$0.17$0.27$1.42 billion$1.3830 billionViewN/AView Earnings Details
5/2/2016Q116$0.02$0.06$1.27 billion$1.2970 billionViewN/AView Earnings Details
2/23/2016Q415$0.09$0.03$1.36 billion$1.40 billionViewListenView Earnings Details
11/5/2015Q315$0.26$0.40$1.52 billion$1.4860 billionViewN/AView Earnings Details
8/6/2015Q215$0.33$0.24$1.53 billion$1.50 billionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

The Chemours (NYSE:CC) Dividend Information

The Chemours pays an annual dividend of $0.68 per share, with a dividend yield of 1.31%. CC's next quarterly dividend payment will be made on Friday, June 15. The Chemours pays out 17.80% of its earnings out as a dividend.
Next Dividend:6/15/2018
Annual Dividend:$0.68
Dividend Yield:1.31%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio(s):17.80% (Trailing 12 Months of Earnings)
11.95% (Based on This Year's Estimates)
10.78% (Based on Next Year's Estimates)
12.50% (Based on Cash Flow)
Frequency:Quarterly Dividend
Dividend Payments by Quarter for The Chemours (NYSE:CC)

The Chemours (NYSE:CC) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/1/2018quarterly$0.171.41%5/16/20185/17/20186/15/2018
12/1/2017Quarterly$0.171.43%2/14/20182/15/20183/15/2018
11/7/2017quarterly$0.030.24%11/17/201711/20/201712/15/2017
8/2/2017quarterly$0.030.25%8/15/20178/17/20179/15/2017
4/27/2017quarterly$0.030.3%5/15/20175/17/20176/15/2017
2/14/2017quarterly$0.030.37%2/23/20172/27/20173/15/2017
11/2/2016quarterly$0.030.72%11/15/201611/17/201612/15/2016
8/3/2016quarterly$0.031.34%8/15/20168/17/20169/15/2016
4/27/2016quarterly$0.031.27%5/13/20165/17/20166/15/2016
2/23/2016quarterly$0.032.44%3/9/20163/11/20163/31/2016
9/1/2015quarterly$0.031.38%11/10/201511/13/201512/14/2015
7/24/2015special$0.557/30/20158/3/20159/11/2015
(Data available from 1/1/2013 forward)

Insider Trades

The Chemours (NYSE CC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.75%
Institutional Ownership Percentage: 76.78%
Insider Trading History for The Chemours (NYSE:CC)
Institutional Ownership by Quarter for The Chemours (NYSE:CC)

The Chemours (NYSE CC) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/9/2018Mark P VergnanoInsiderSell200,151$50.47$10,101,620.97394,299View SEC Filing  
5/8/2018Mark NewmanCFOSell43,675$50.04$2,185,497.00125,399View SEC Filing  
4/17/2018Erich ParkerSVPSell5,000$52.00$260,000.00View SEC Filing  
3/9/2018Mark NewmanVPSell29,381$49.19$1,445,251.39View SEC Filing  
2/20/2018Paul KirschInsiderSell13,770$50.01$688,637.7063,093View SEC Filing  
12/13/2017Christian W. SiemerInsiderSell15,088$47.37$714,718.56View SEC Filing  
11/6/2017E Bryan SnellInsiderSell11,878$53.25$632,503.5063,063View SEC Filing  
10/13/2017David C SheltonSVPSell5,908$56.01$330,907.0847,356View SEC Filing  
10/10/2017David C SheltonSVPSell13,397$55.00$736,835.00View SEC Filing  
10/5/2017David C SheltonSVPSell19,000$53.68$1,019,920.00View SEC Filing  
9/5/2017E Bryan SnellInsiderSell13,000$49.35$641,550.00View SEC Filing  
8/31/2017David C. SheltonSVPSell13,337$48.48$646,577.76View SEC Filing  
8/11/2017Amy TrojanowskiVPSell2,500$46.03$115,075.00View SEC Filing  
8/11/2017E Bryan SnellInsiderSell10,000$46.24$462,400.00View SEC Filing  
6/5/2017Paul KirschInsiderSell19,036$41.42$788,471.12View SEC Filing  
5/16/2017Erich ParkerVPSell4,908$45.53$223,461.24View SEC Filing  
5/5/2017Mark NewmanVPSell22,781$39.83$907,367.23View SEC Filing  
5/3/2017Richard H. BrownDirectorBuy2,500$39.10$97,750.00View SEC Filing  
5/13/2016Mark NewmanCFOBuy2,800$9.71$27,188.00108,533View SEC Filing  
5/4/2016Bradley J BellDirectorBuy10,000$9.65$96,500.0021,747View SEC Filing  
2/26/2016Stephen D. NewlinDirectorBuy10,000$4.94$49,400.00View SEC Filing  
11/23/2015Thierry Fj VanlanckerInsiderBuy15,000$6.00$90,000.00190,022View SEC Filing  
9/14/2015E Bryan SnellInsiderBuy8,000$8.89$71,120.0022,051View SEC Filing  
9/11/2015Amy TrojanowskiVPBuy5,400$9.24$49,896.0011,982View SEC Filing  
9/10/2015Christian W SiemerInsiderBuy10,100$9.39$94,839.0031,843View SEC Filing  
9/9/2015Mark NewmanCFOBuy10,600$9.32$98,792.00114,109View SEC Filing  
9/8/2015Christian W SiemerInsiderBuy11,000$9.11$100,210.0021,743View SEC Filing  
9/4/2015David C SheltonSVPBuy5,000$9.00$45,000.0013,183View SEC Filing  
9/4/2015Mark P VergnanoCEOBuy72,600$9.25$671,550.00321,337View SEC Filing  
9/4/2015Stephen D. NewlinDirectorBuy7,000$9.18$64,260.0016,680View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

The Chemours (NYSE CC) News Headlines

Source:
DateHeadline
BRIEF-Chemours Announces Pricing Of Public Offering Of €450 Million Of 4.000% Senior Notes Due 2026BRIEF-Chemours Announces Pricing Of Public Offering Of €450 Million Of 4.000% Senior Notes Due 2026
www.reuters.com - May 22 at 4:16 PM
NHL Partners With The Chemours Company to Provide Sustainable Solutions To Community Rinks Across North AmericaNHL Partners With The Chemours Company to Provide Sustainable Solutions To Community Rinks Across North America
finance.yahoo.com - May 22 at 4:16 PM
Chemours Announces Pricing Of Public Offering Of €450 Million Of 4.000% Senior Notes Due 2026Chemours Announces Pricing Of Public Offering Of €450 Million Of 4.000% Senior Notes Due 2026
finance.yahoo.com - May 22 at 4:16 PM
Chemours Makes Fortune 500 List a Second Consecutive YearChemours Makes Fortune 500 List a Second Consecutive Year
www.prnewswire.com - May 21 at 8:51 PM
Chemours Company, (The) -- Moodys assigns Ba3 to Chemours New Senior Unsecured NotesChemours Company, (The) -- Moody's assigns Ba3 to Chemours' New Senior Unsecured Notes
finance.yahoo.com - May 21 at 4:16 PM
The Chemours (CC) Earns Buy Rating from Analysts at Vertical ResearchThe Chemours (CC) Earns Buy Rating from Analysts at Vertical Research
www.americanbankingnews.com - May 21 at 10:54 AM
BRIEF-Chemours Announces Commencement Of Public Offering Of Senior NotesBRIEF-Chemours Announces Commencement Of Public Offering Of Senior Notes
www.reuters.com - May 21 at 9:46 AM
Yamana Gold (AUY) Produces First Gold & Silver at Cerro MoroYamana Gold (AUY) Produces First Gold & Silver at Cerro Moro
www.zacks.com - May 21 at 9:46 AM
Has Chemours (CC) Outpaced Other Basic Materials Stocks This Year?Has Chemours (CC) Outpaced Other Basic Materials Stocks This Year?
www.zacks.com - May 21 at 9:46 AM
The Chemours Company Announces Conditional Cash Tender Offer And Consent Solicitation Of Up To $250,000,000 Of 6.625% Senior Notes Maturing In 2023The Chemours Company Announces Conditional Cash Tender Offer And Consent Solicitation Of Up To $250,000,000 Of 6.625% Senior Notes Maturing In 2023
finance.yahoo.com - May 21 at 9:45 AM
The Chemours Company Announces Conditional Cash Tender Offer And Consent Solicitation And Redemption Of 6.125% Senior Notes Maturing In 2023The Chemours Company Announces Conditional Cash Tender Offer And Consent Solicitation And Redemption Of 6.125% Senior Notes Maturing In 2023
finance.yahoo.com - May 21 at 9:45 AM
Inspire Awards 2018: Mary Cranston on why women need to push back on stereotypes about leadershipInspire Awards 2018: Mary Cranston on why women need to push back on stereotypes about leadership
finance.yahoo.com - May 17 at 4:13 PM
The Chemours Companys Barbara H. Minor Awarded Prestigious Perkin MedalThe Chemours Company's Barbara H. Minor Awarded Prestigious Perkin Medal
finance.yahoo.com - May 17 at 4:13 PM
Zacks.com highlights: Chemours, Boise Cascade, Louisiana-Pacific, Seagate Technology and Meet GroupZacks.com highlights: Chemours, Boise Cascade, Louisiana-Pacific, Seagate Technology and Meet Group
finance.yahoo.com - May 16 at 4:19 PM
Form 4 Chemours Co For: May 08 Filed by: Newman MarkForm 4 Chemours Co For: May 08 Filed by: Newman Mark
www.streetinsider.com - May 11 at 4:25 PM
Insider Selling: The Chemours Company (CC) CFO Sells 43,675 Shares of StockInsider Selling: The Chemours Company (CC) CFO Sells 43,675 Shares of Stock
www.americanbankingnews.com - May 10 at 10:32 PM
The Chemours Company (CC) Insider Sells $10,101,620.97 in StockThe Chemours Company (CC) Insider Sells $10,101,620.97 in Stock
www.americanbankingnews.com - May 10 at 10:14 PM
Chemours (CC) PT Raised to $70 at BMO Capital; Remains Top PickChemours (CC) PT Raised to $70 at BMO Capital; Remains Top Pick
www.streetinsider.com - May 8 at 4:17 PM
The Chemours (CC) Buy Rating Reiterated at BarclaysThe Chemours' (CC) Buy Rating Reiterated at Barclays
www.americanbankingnews.com - May 8 at 3:45 PM
The Chemours (CC) Price Target Increased to $69.00 by Analysts at CitigroupThe Chemours (CC) Price Target Increased to $69.00 by Analysts at Citigroup
www.americanbankingnews.com - May 8 at 11:02 AM
Chemours Announces Sodium Cyanide Price IncreaseChemours Announces Sodium Cyanide Price Increase
finance.yahoo.com - May 8 at 9:41 AM
Has Chemours Company (CC) Outpaced Other Basic Materials Stocks This Year?Has Chemours Company (CC) Outpaced Other Basic Materials Stocks This Year?
finance.yahoo.com - May 7 at 10:10 AM
Form 4 Chemours Co For: May 02 Filed by: Farrell Dawn LForm 4 Chemours Co For: May 02 Filed by: Farrell Dawn L
www.streetinsider.com - May 6 at 4:21 PM
Edited Transcript of CC earnings conference call or presentation 4-May-18 12:30pm GMTEdited Transcript of CC earnings conference call or presentation 4-May-18 12:30pm GMT
finance.yahoo.com - May 5 at 9:56 AM
Financial Comparison: The Chemours (CC) and Johnson Matthey (JMPLY)Financial Comparison: The Chemours (CC) and Johnson Matthey (JMPLY)
www.americanbankingnews.com - May 4 at 5:29 PM
The Chemours Company Reports First Quarter 2018 Results, Doubling Earnings Year-over-YearThe Chemours Company Reports First Quarter 2018 Results, Doubling Earnings Year-over-Year
finance.yahoo.com - May 4 at 4:19 PM
Chemours: 1Q Earnings SnapshotChemours: 1Q Earnings Snapshot
finance.yahoo.com - May 4 at 9:33 AM
Chemours beats by $0.20, beats on revenueChemours beats by $0.20, beats on revenue
seekingalpha.com - May 4 at 9:33 AM
The Chemours Company Names Jonathan Lock as Vice President of Corporate Development and Investor RelationsThe Chemours Company Names Jonathan Lock as Vice President of Corporate Development and Investor Relations
www.prnewswire.com - May 4 at 7:30 AM
The Chemours (CC) Releases Quarterly  Earnings Results, Beats Estimates By $0.29 EPSThe Chemours (CC) Releases Quarterly Earnings Results, Beats Estimates By $0.29 EPS
www.americanbankingnews.com - May 4 at 12:30 AM
The Chemours Company Declares Quarterly Dividend of $0.17 (CC)The Chemours Company Declares Quarterly Dividend of $0.17 (CC)
www.americanbankingnews.com - May 1 at 9:30 PM
The Chemours Company (CC) Given Average Recommendation of "Buy" by AnalystsThe Chemours Company (CC) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - April 30 at 1:36 PM
Notable Two Hundred Day Moving Average Cross - CCNotable Two Hundred Day Moving Average Cross - CC
www.nasdaq.com - April 27 at 4:05 PM
The Chemours (CC) & Innospec (IOSP) Financial ContrastThe Chemours (CC) & Innospec (IOSP) Financial Contrast
www.americanbankingnews.com - April 26 at 7:46 AM
The Chemours (CC) Set to Announce Quarterly Earnings on ThursdayThe Chemours (CC) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - April 26 at 1:41 AM
Chemours CEO Receives Top Industry Honor for Innovation & Professional ImpactChemours CEO Receives Top Industry Honor for Innovation & Professional Impact
finance.yahoo.com - April 23 at 9:56 AM
The Chemours (CC) Stock Rating Reaffirmed by UBSThe Chemours (CC) Stock Rating Reaffirmed by UBS
www.americanbankingnews.com - April 20 at 9:46 PM
The Chemours Company (CC) SVP Sells $260,000.00 in StockThe Chemours Company (CC) SVP Sells $260,000.00 in Stock
www.americanbankingnews.com - April 19 at 10:10 PM
Chemours (CC) Stock Rating Upgraded by BidaskClubChemours (CC) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - April 18 at 6:54 PM
Fast and loose: Plaintiffs respond to motion to dismiss GenX case'Fast and loose': Plaintiffs respond to motion to dismiss GenX case
www.bizjournals.com - April 17 at 9:53 AM
'Fast and loose': Plaintiffs respond to motion to dismiss GenX case'Fast and loose': Plaintiffs respond to motion to dismiss GenX case
finance.yahoo.com - April 16 at 4:22 PM
Jefferies Group Raises Chemours (CC) Price Target to $60.00Jefferies Group Raises Chemours (CC) Price Target to $60.00
www.americanbankingnews.com - April 13 at 7:49 PM
Chemours (CC) Rating Increased to Neutral at UBSChemours (CC) Rating Increased to Neutral at UBS
www.americanbankingnews.com - April 13 at 12:58 AM
June 1st Options Now Available For Chemours (CC)June 1st Options Now Available For Chemours (CC)
www.nasdaq.com - April 12 at 4:19 PM
Why Chemours Company (CC) Could Beat Earnings Estimates Again April 11, 2018Why Chemours Company (CC) Could Beat Earnings Estimates Again April 11, 2018
www.zacks.com - April 12 at 10:38 AM
Why Chemours Company (CC) Could Beat Earnings Estimates AgainWhy Chemours Company (CC) Could Beat Earnings Estimates Again
finance.yahoo.com - April 11 at 10:28 AM
Citigroup Lowers Chemours (CC) Price Target to $66.00Citigroup Lowers Chemours (CC) Price Target to $66.00
www.americanbankingnews.com - April 10 at 11:29 AM
NC puts Chemours on notice over GenX air emissionsNC puts Chemours on notice over GenX air emissions
www.bizjournals.com - April 9 at 4:16 PM
Why Chemours Company (CC) Could Be an Impressive Growth Stock April 09, 2018Why Chemours Company (CC) Could Be an Impressive Growth Stock April 09, 2018
www.zacks.com - April 9 at 4:16 PM
Analyzing Innospec (IOSP) and Chemours (CC)Analyzing Innospec (IOSP) and Chemours (CC)
www.americanbankingnews.com - April 6 at 9:26 PM

SEC Filings

The Chemours (NYSE:CC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

The Chemours (NYSE:CC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

The Chemours (NYSE CC) Stock Chart for Wednesday, May, 23, 2018

Loading chart…

This page was last updated on 5/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.